JP4974015B2 - モミの木の抽出物での脳の精神的安定化材料 - Google Patents
モミの木の抽出物での脳の精神的安定化材料 Download PDFInfo
- Publication number
- JP4974015B2 JP4974015B2 JP2009256706A JP2009256706A JP4974015B2 JP 4974015 B2 JP4974015 B2 JP 4974015B2 JP 2009256706 A JP2009256706 A JP 2009256706A JP 2009256706 A JP2009256706 A JP 2009256706A JP 4974015 B2 JP4974015 B2 JP 4974015B2
- Authority
- JP
- Japan
- Prior art keywords
- fir
- essential oil
- pinene
- fir tree
- limonene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000004556 brain Anatomy 0.000 title claims description 12
- 239000000284 extract Substances 0.000 title claims description 11
- 239000000463 material Substances 0.000 title claims description 7
- 230000003340 mental effect Effects 0.000 title description 8
- 230000006641 stabilisation Effects 0.000 title description 6
- 238000011105 stabilization Methods 0.000 title description 6
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims description 57
- KGEKLUUHTZCSIP-HOSYDEDBSA-N [(1s,4s,6r)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Chemical compound C1C[C@]2(C)[C@H](OC(=O)C)C[C@H]1C2(C)C KGEKLUUHTZCSIP-HOSYDEDBSA-N 0.000 claims description 56
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 claims description 39
- 235000001510 limonene Nutrition 0.000 claims description 29
- 229940087305 limonene Drugs 0.000 claims description 29
- 229940115397 bornyl acetate Drugs 0.000 claims description 28
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 claims description 26
- -1 pinene Chemical compound 0.000 claims description 21
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 claims description 19
- 229930006739 camphene Natural products 0.000 claims description 19
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 claims description 19
- 239000004480 active ingredient Substances 0.000 claims description 9
- 241000379194 Abies sibirica Species 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 2
- 230000000087 stabilizing effect Effects 0.000 claims 1
- 239000000341 volatile oil Substances 0.000 description 64
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 39
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 20
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 20
- 230000000694 effects Effects 0.000 description 19
- 150000003505 terpenes Chemical class 0.000 description 12
- 235000007586 terpenes Nutrition 0.000 description 12
- WRYLYDPHFGVWKC-UHFFFAOYSA-N 4-terpineol Chemical compound CC(C)C1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-UHFFFAOYSA-N 0.000 description 10
- 239000012567 medical material Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 7
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 229930006722 beta-pinene Natural products 0.000 description 7
- BQOFWKZOCNGFEC-UHFFFAOYSA-N carene Chemical compound C1C(C)=CCC2C(C)(C)C12 BQOFWKZOCNGFEC-UHFFFAOYSA-N 0.000 description 7
- 239000002537 cosmetic Substances 0.000 description 7
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 7
- 238000010586 diagram Methods 0.000 description 6
- 229930014626 natural product Natural products 0.000 description 6
- NDVASEGYNIMXJL-UHFFFAOYSA-N sabinene Chemical compound C=C1CCC2(C(C)C)C1C2 NDVASEGYNIMXJL-UHFFFAOYSA-N 0.000 description 6
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 5
- WRYLYDPHFGVWKC-SNVBAGLBSA-N 4-Terpineol Natural products CC(C)[C@]1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-SNVBAGLBSA-N 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 238000001256 steam distillation Methods 0.000 description 5
- 241000218642 Abies Species 0.000 description 4
- 241000218631 Coniferophyta Species 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- IGODOXYLBBXFDW-UHFFFAOYSA-N alpha-Terpinyl acetate Chemical compound CC(=O)OC(C)(C)C1CCC(C)=CC1 IGODOXYLBBXFDW-UHFFFAOYSA-N 0.000 description 4
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 230000035882 stress Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- YKFLAYDHMOASIY-UHFFFAOYSA-N γ-terpinene Chemical compound CC(C)C1=CCC(C)=CC1 YKFLAYDHMOASIY-UHFFFAOYSA-N 0.000 description 4
- NDVASEGYNIMXJL-NXEZZACHSA-N (+)-sabinene Natural products C=C1CC[C@@]2(C(C)C)[C@@H]1C2 NDVASEGYNIMXJL-NXEZZACHSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- LLKXNMNOHBQSJW-UHFFFAOYSA-N Elemol Natural products CCC(=C)C1CC(C=CC1(C)C)C(C)(C)O LLKXNMNOHBQSJW-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- KQAZVFVOEIRWHN-UHFFFAOYSA-N alpha-thujene Natural products CC1=CCC2(C(C)C)C1C2 KQAZVFVOEIRWHN-UHFFFAOYSA-N 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 229930006737 car-3-ene Natural products 0.000 description 3
- 229930007796 carene Natural products 0.000 description 3
- GFJIQNADMLPFOW-UHFFFAOYSA-N cis-Elemol Natural products CC(=C)C1CC(C(C)(C)O)CCC1(C)C=C GFJIQNADMLPFOW-UHFFFAOYSA-N 0.000 description 3
- GFJIQNADMLPFOW-VNHYZAJKSA-N elemol Chemical compound CC(=C)[C@@H]1C[C@H](C(C)(C)O)CC[C@@]1(C)C=C GFJIQNADMLPFOW-VNHYZAJKSA-N 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000000077 insect repellent Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229930003658 monoterpene Natural products 0.000 description 3
- 235000002577 monoterpenes Nutrition 0.000 description 3
- 210000005037 parasympathetic nerve Anatomy 0.000 description 3
- 229930006696 sabinene Natural products 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- CRPUJAZIXJMDBK-DTWKUNHWSA-N (+)-camphene Chemical compound C1C[C@@H]2C(=C)C(C)(C)[C@H]1C2 CRPUJAZIXJMDBK-DTWKUNHWSA-N 0.000 description 2
- OPFTUNCRGUEPRZ-QLFBSQMISA-N (-)-beta-elemene Chemical compound CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C(C)=C)C1 OPFTUNCRGUEPRZ-QLFBSQMISA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- TZNXGARVNMCICB-UHFFFAOYSA-N Camphen Natural products C1CC2C(C)(C)C(=C)C1C2(C)C TZNXGARVNMCICB-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- IGODOXYLBBXFDW-NSHDSACASA-N alpha-Terpinyl acetate Natural products CC(=O)OC(C)(C)[C@@H]1CCC(C)=CC1 IGODOXYLBBXFDW-NSHDSACASA-N 0.000 description 2
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 230000001076 estrogenic effect Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000008035 nerve activity Effects 0.000 description 2
- 229920002620 polyvinyl fluoride Polymers 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 2
- OPFTUNCRGUEPRZ-UHFFFAOYSA-N (+)-beta-Elemen Natural products CC(=C)C1CCC(C)(C=C)C(C(C)=C)C1 OPFTUNCRGUEPRZ-UHFFFAOYSA-N 0.000 description 1
- GAIBLDCXCZKKJE-QRYCCKSOSA-N (-)-Germacrene D Natural products C(C)(C)[C@H]1/C=C/C(=C)CC/C=C(/C)\CC1 GAIBLDCXCZKKJE-QRYCCKSOSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- WWJLCYHYLZZXBE-UHFFFAOYSA-N 5-chloro-1,3-dihydroindol-2-one Chemical compound ClC1=CC=C2NC(=O)CC2=C1 WWJLCYHYLZZXBE-UHFFFAOYSA-N 0.000 description 1
- NVEQFIOZRFFVFW-UHFFFAOYSA-N 9-epi-beta-caryophyllene oxide Natural products C=C1CCC2OC2(C)CCC2C(C)(C)CC21 NVEQFIOZRFFVFW-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 241000218691 Cupressaceae Species 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 244000166124 Eucalyptus globulus Species 0.000 description 1
- PSMFFFUWSMZAPB-UHFFFAOYSA-N Eukalyptol Natural products C1CC2CCC1(C)COCC2(C)C PSMFFFUWSMZAPB-UHFFFAOYSA-N 0.000 description 1
- GAIBLDCXCZKKJE-YZJXYJLZSA-N Germacren D Chemical compound CC(C)C/1CC\C(C)=C\CCC(=C)\C=C\1 GAIBLDCXCZKKJE-YZJXYJLZSA-N 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- KGEKLUUHTZCSIP-UHFFFAOYSA-N Isobornyl acetate Natural products C1CC2(C)C(OC(=O)C)CC1C2(C)C KGEKLUUHTZCSIP-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 241000218652 Larix Species 0.000 description 1
- 235000005590 Larix decidua Nutrition 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 240000008670 Pinus densiflora Species 0.000 description 1
- 235000000405 Pinus densiflora Nutrition 0.000 description 1
- 241000736892 Thujopsis dolabrata Species 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000001940 [(1R,4S,6R)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- FAMPSKZZVDUYOS-UHFFFAOYSA-N alpha-Caryophyllene Natural products CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- 125000003447 alpha-pinene group Chemical group 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 238000000222 aromatherapy Methods 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- 150000001591 beta-pinene derivatives Chemical class 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- PNKMVYJSEIXTJQ-UHFFFAOYSA-N boranyl acetate Chemical compound BOC(C)=O PNKMVYJSEIXTJQ-UHFFFAOYSA-N 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940117948 caryophyllene Drugs 0.000 description 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000000850 decongestant Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000001490 effect on brain Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 238000010413 gardening Methods 0.000 description 1
- HIGQPQRQIQDZMP-UHFFFAOYSA-N geranil acetate Natural products CC(C)=CCCC(C)=CCOC(C)=O HIGQPQRQIQDZMP-UHFFFAOYSA-N 0.000 description 1
- HIGQPQRQIQDZMP-DHZHZOJOSA-N geranyl acetate Chemical compound CC(C)=CCC\C(C)=C\COC(C)=O HIGQPQRQIQDZMP-DHZHZOJOSA-N 0.000 description 1
- OJIGFVZZEVQUNV-UHFFFAOYSA-N germacrene D Natural products CC(C)C1CCC=C(/C)CCC(=C)C=C1 OJIGFVZZEVQUNV-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000010030 glucose lowering effect Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 229940124452 immunizing agent Drugs 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- GAIBLDCXCZKKJE-UHFFFAOYSA-N isogermacrene D Natural products CC(C)C1CCC(C)=CCCC(=C)C=C1 GAIBLDCXCZKKJE-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000001459 whitebark Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Description
主成分として、ピネン、カンフェン、リモネン及びボルニルアセテートを含む混合物(特許文献7参照)、またブルーミング香料成分として、カンフェン、イソボルニルアセテート、リモネン、ピネンの成分(特許文献8参照)の記載がある。
ボルニルアセテートとカンフェンとピネンとリモネンとカレンを有効成分とする植物性エッセンスである。ボルニルアセテートとカンフェンとピネンとリモネンとカレンなどを90重量%以上含有するテルペン類の高濃度含有物の形態で提供される。
またα−ピネン、カレンなどのモノテルペン類の炭化水素類を25%以上と含有しており、α−ピネンはほとんどの精油に含まれている成分で殺菌作用、抗菌作用、うっ血除去作用、ステロイドホルモン作用、鎮痛作用、むくみを除去する作用(腎臓機能を高め利尿作用)がある。鎮痛、殺菌、血糖値降下、脂肪溶解、消炎・鎮痛作用、精神安定作用に有効である。
2)入浴剤として、浴槽に数滴たらす。揮発成分が精神を安定させ、精油が肌を活性化する。
3)微量の吸引によって、安眠、安息、精神的安定に効果を示す。
4)脳波の・・帯域に影響して、より深い睡眠状態を増大させる
本来森林浴は、主に樹木から放出される木の匂いにより、ストレスを解消し、やすらぎを与え副交感神経の活動を活発化することにある。木の匂いは主として、葉、幹、あるいは花から放出される揮発性の物で揮発性のフィトンチッドとして、我々の体に、ストレスを解消させたり、脈拍を減少させたり、血圧を低下させたりする。
・ Sample;モミの木の精油(アセトンで1000倍に希釈)、(A)と(B)の2種類の試料
・ GC−MS;ShimadzuGC−17A(GC)、ShimadzuQP5050(MS)
Column;30m×0.25mmID×0.25μm、SPB−50ven Temp;40℃(hold 1min)to245℃@10℃/min(hold 18min)to320℃@10℃/min(hold 1min)Injection;Split,1/50
上記のサンプルのGC−MSの分析の結果図を図2に示す。また主要成分のマススペクトル図を図3に示した。また分析結果と状態をAとBに示した。
それぞれの成分の相対比(ピーク面積)はα−Pinene,、Camphen,β−Pinene、Limonene,Bornyl acetate、δ3careneであり、ボルニルアセテート、ピネンが多く含有されている
物質名 Aの含有量(%) Bの含有量(%)
1)ボルニルアセテート 30.0 14.2
2)α−ピネン 17.1 41.5
3)カンフェン 20.1 11.5
4)β−ピネン 5.7 2.0
5)リモネン 10.5 5.0
6)カレン 13.3
上記の二種類のモミの木の精油の性状は、芳香をもつ無色あるいは淡黄色の揮発性、可燃性液体で、水にはほとんど不溶、動植物油脂と任意の割合で溶け合う。20℃における密度0.887/cm3、 屈折率 1.4682、 酸性度0.49である。
供試試料から揮発成分の提示口までは、内径0.5cm×1.5mステンレス管で繋ぎ、揮発成分提示口から被験者の鼻先までの距離は15cmとした。生理学的な変化を捉える指標として、脳波α、β、δ、θ帯域と心電図を測定した。
B.:B採取の成分
1.ボルニルアセテート
2.α−ピネン
3.カンフェン
4.β−ピネン
5.リモネン
6.カレン
Claims (1)
- シベリア産モミの木と葉を水蒸気蒸留し、その留出物を冷却分離して得た、カンフェンとピネンとリモネンとボルニルアセテートとカレンとの主要有効成分を90重量%以上含有するモミの木の抽出物であることを特徴とする脳波のθ帯域に影響を与える、脳の精神的安定化材料
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009256706A JP4974015B2 (ja) | 2009-11-10 | 2009-11-10 | モミの木の抽出物での脳の精神的安定化材料 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009256706A JP4974015B2 (ja) | 2009-11-10 | 2009-11-10 | モミの木の抽出物での脳の精神的安定化材料 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2011102245A JP2011102245A (ja) | 2011-05-26 |
JP4974015B2 true JP4974015B2 (ja) | 2012-07-11 |
Family
ID=44192756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009256706A Active JP4974015B2 (ja) | 2009-11-10 | 2009-11-10 | モミの木の抽出物での脳の精神的安定化材料 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4974015B2 (ja) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013256448A (ja) * | 2012-06-11 | 2013-12-26 | Kao Corp | 美白剤 |
JP5944296B2 (ja) * | 2012-10-29 | 2016-07-05 | 学校法人昭和薬科大学 | 口腔疾患の治療剤、およびその製造方法 |
JP2014224073A (ja) * | 2013-05-16 | 2014-12-04 | 地方独立行政法人北海道立総合研究機構 | マツ科モミ属植物の樹葉の抽出物を含有するエラスターゼ活性抑制剤 |
KR102059852B1 (ko) * | 2013-11-20 | 2019-12-27 | 주식회사 엘지생활건강 | 한방향 유효성분 보닐아세테이트(Bornyl Acetate) 를 피부 유용성분으로 함유하는 화장료 조성물 |
JP6535853B2 (ja) * | 2014-11-12 | 2019-07-03 | 三笠製薬株式会社 | 抗炎症外用剤 |
JP6959594B2 (ja) * | 2014-11-12 | 2021-11-02 | 三笠製薬株式会社 | 抗炎症外用剤 |
JP2016150936A (ja) * | 2015-02-19 | 2016-08-22 | 株式会社ゼックフィールド | 睡眠補助材 |
SI25053A (sl) * | 2015-09-10 | 2017-03-31 | Abies Labs D.O.O. | Izvleček iz lesa dreves iz rodu jelka za preprečevanje, lajšanje in zdravljenje neželenih sprememb kože ter pripravki |
JP6694289B2 (ja) * | 2016-02-12 | 2020-05-13 | 株式会社日立製作所 | 薬効評価補助システム、及び薬効評価補助情報提示方法 |
JP2017178874A (ja) * | 2016-03-31 | 2017-10-05 | エステー株式会社 | 鎮痛剤 |
JP2019137641A (ja) * | 2018-02-13 | 2019-08-22 | 広一 溝口 | テルペノイド類を含む抗かゆみ用組成物 |
JP7106345B2 (ja) * | 2018-05-10 | 2022-07-26 | エステー株式会社 | 歯周病抑制剤およびこれを利用する口腔用組成物 |
KR102644603B1 (ko) * | 2018-10-16 | 2024-03-07 | (주)아모레퍼시픽 | 북양전나무 오일을 포함하는 피부 장벽 강화용 조성물 |
CN114306138A (zh) * | 2021-12-20 | 2022-04-12 | 南京泛成生物科技有限公司 | 一种含有氯苯苷醚的防腐剂组合物及其制备方法和应用 |
CN114432350B (zh) * | 2022-03-17 | 2023-04-07 | 广西壮族自治区中医药研究院 | 一种杉木叶精油及其应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0320559U (ja) * | 1989-07-04 | 1991-02-28 | ||
IT1295357B1 (it) * | 1997-10-17 | 1999-05-12 | Giancarlo Verona | Formulazioni cosmetiche utili nel trattamento preventivo e curativo della caduta dei capelli e loro uso |
JP2001064163A (ja) * | 1999-08-31 | 2001-03-13 | Figla Co Ltd | 抗菌剤 |
EP1344516A1 (de) * | 2002-03-12 | 2003-09-17 | Cognis Iberia, S.L. | Antioxidative Zubereitungen |
EP1711194B1 (en) * | 2003-10-24 | 2009-11-25 | Cognis France, S.A.S. | A plant extract and its pharmaceutical and cosmetic use |
JP5537893B2 (ja) * | 2009-10-14 | 2014-07-02 | 株式会社ゼックフィールド | 抗インフルエンザウイルスa型剤 |
JP3168739U (ja) * | 2011-01-24 | 2011-06-30 | 株式会社ゼックフィールド | 霧発生装置付き容器入りテルペン系モミの木精油成分の防菌・防虫・消臭剤 |
-
2009
- 2009-11-10 JP JP2009256706A patent/JP4974015B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP2011102245A (ja) | 2011-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4974015B2 (ja) | モミの木の抽出物での脳の精神的安定化材料 | |
US20050158264A1 (en) | Sympathetic nerve-stimulating fragrant compositions | |
US9248320B2 (en) | Perfume and cosmetic composition with anti-stress and relaxing effect | |
KR101230388B1 (ko) | 소나무로부터 정유를 추출하는 방법 및 이 방법으로 추출한 소나무 정유 | |
KR20120131970A (ko) | 스트레스 완화 및 진정 효과를 갖는 향료 조성물 및 이를 함유하는 화장료 조성물 | |
KR101729919B1 (ko) | 천연 정유 및 천연 하이드로졸을 함유하는 아로마테라피 효과가 있는 바디오일 조성물 | |
CN108078814A (zh) | 一种具有驱蚊功效的植物芳香油组合物及其在化妆品中的应用 | |
Sharma et al. | Health benefits of lavender (Lavandula angustifolia) | |
CN111135209A (zh) | 一种具有防疟驱蚊止痒修复的青蒿喷剂及其制备方法 | |
CN108379639A (zh) | 一种空气清新剂及其制备方法 | |
WO2019011664A1 (en) | COMPOSITION COMPRISING A FRAGRANCE FOR USE AS A REHABILITATION COMPOSITION FOR TOXICOMANS | |
JP2002265977A (ja) | 交感神経活性化香料組成物 | |
JP2016150936A (ja) | 睡眠補助材 | |
CN113769024B (zh) | 一种改善情绪的复方精油及其制备方法和应用 | |
KR102570019B1 (ko) | 아로마테라피 효과가 있는 발마사지용 화장료 조성물 | |
JP2014005403A (ja) | 香料組成物および化粧料 | |
KR101175656B1 (ko) | 한방 방향제 조성물 | |
RU2093171C1 (ru) | Лекарственное средство | |
Buchbauer | Lavender oil and its therapeutic properties | |
JPH11209294A (ja) | 精油を有効成分とする副交感神経作用剤 | |
JP2019218292A (ja) | 睡眠導入、安眠機能促進および改善剤 | |
KR102276638B1 (ko) | 편백유와 편백수를 함유하는 포 및 그 제조방법 | |
Naz et al. | Synthesis and Uses of various essential oil based derivatives in biomedicine | |
US11602701B2 (en) | Method for extraction and isolation of cannabis terpene and aromatic isolates from cannabis sativa and cannabis indica | |
Debbab et al. | Chemical characterization and toxicological evaluation of the essential oil of Mentha piperita L. growing in Morocco |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20110808 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110808 |
|
A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20111110 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111122 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120117 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120327 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120329 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4974015 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150420 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |